Philip Tracy

Statistics

Publications

Citations

703

H-Index

Active since

2017

Affiliations

Tufts University(Current)

Levine Cancer Institute

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Philip Tracy is an author at Tufts University specializing in therapeutic resistance, molecular oncology, and resistance to tyrosine kinase inhibitors.

Publications per year

2017–2018

Publications

Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham et al. · JAMA Oncology · 2018 · 689 citations · Full text

Medicine, Oncology, Pharmacology +17

OA 09.02 Osimertinib Resistance Mediated by Loss of EGFR T790M Is Associated with Early Resistance and Competing Resistance Mechanisms

Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham et al. · Journal of Thoracic Oncology · 2017 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

1–2 of 2